Assam to vaccinate everyone in 18-45 age group for free: Himanta Sarma

The Assam government will vaccinate everyone in the 18-45 age group for free from May 1 onwards, Health Minister Himanta Biswa Sarma has said

Himanta Biswa Sarma
Press Trust of India Guwahati
3 min read Last Updated : Apr 21 2021 | 12:59 PM IST

The Assam government will

vaccinate everyone in the 18-45 age group for free from May 1 onwards, Health Minister Himanta Biswa Sarma has said.

Donations received last year for COVID management will be utilised for the purpose, he said.

The state Health Department has already written to Covaxin maker Bharat Biotech for procuring 1 crore vaccines.

"Assam will give FREE vaccines to everyone from 18-45 years. GOI is giving free vaccines for 45+," Sarma tweeted late on Tuesday.

Funds collected in Asom Arogya Nidhi account last year shall be utilised for procuring the vaccines, he said.

"Today itself, we've placed orders for 1 cr doses with @BharatBiotech," the health minister said.

In September last year, Sarma had informed the Assembly that a total of Rs 116.1 crore contribution from 53,534 people have been received in the account of the Asom Arogya Nidhi to support the government's efforts in handling the pandemic.

The Centre had announced on April 19 that everyone above 18 years of age will be eligible for COVID-19 vaccination from May 1, while private hospitals and states will be able to buy doses from manufacturers.

It also said that vaccine manufacturers will be free to supply 50 per cent doses to state governments and in the open market, for which they will have to make an advance declaration of the price before May 1.

In a letter to the Bharat Biotech chairman and MD on Tuesday, Assam Principal Secretary (Health and Family Welfare) Samir K Sinha expressed interest to procure one crore doses of Covaxin at the rate to be fixed by the central government.

"For this purpose, the terms and conditions of delivery and payment along with schedule of supplies may please be intimated at the earliest," he wrote.

The principal secretary mentioned that the National Health Mission (NHM), Assam will be the nodal agency for this procurement under the 'Liberalised and Accelerated Phase 3 Strategy' of the National COVID-19 Vaccination Programme.

Sinha had told reporters on Tuesday that the Assam government had urged the Centre to send an adequate number of COVID-19 vaccine vials as the state's stock will be exhausted in 6-7 days.

He said that the state has received a total of 22,93,470 vaccines, comprising 17,52,830 doses of Covishield and 5,40,640 doses of Covaxin, while there is a stock of 5,03,550 vaccines at present.

Meanwhile, the administration of Kamrup Metropolitan district, which primarily comprises Guwahati, has instructed private hospitals to tie up with hotels so that asymptomatic patients can be shifted there in case of a shortage of hospital beds.

The state reported three more deaths due to COVID-19 on Tuesday, while the number of fresh cases rose sharply with 1,651 people testing positive, pushing the tally to 2,27,473.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusAssamCoronavirus Vaccine

First Published: Apr 21 2021 | 12:52 PM IST

Next Story